Skip to main content
. 2018 Dec 17;24(7):e542–e550. doi: 10.1634/theoncologist.2018-0542

Table 1. Baseline characteristics.

image

Data are from the intention‐to‐treat population.

a

Cox univariate analysis for progression‐free survival.

b

Others include metacarpus and distal tibia and fibula.

c

MAP/I, including high‐dose methotrexate, doxorubicin, cisplatin, and ifosfamide. We defined those four agents as first‐line chemotherapy.

d

Other diseases, including hypertension or diabetes but without tumors.

Abbreviation: ECOG, Eastern Cooperative Oncology Group.